<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01802710</url>
  </required_header>
  <id_info>
    <org_study_id>2008111005</org_study_id>
    <nct_id>NCT01802710</nct_id>
  </id_info>
  <brief_title>Clinical Improvement and in Quality of Life-Functional Dyspepsia-</brief_title>
  <official_title>Influence of the Combined Psychological and Medical Treatment in the Improvement of Symptoms and Quality of Life in Patients With Functional Dyspepsia</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Hospital Galdakao-Usansolo</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Hospital Galdakao-Usansolo</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Functional dyspepsia (FD)is defined as the presence of symptoms thought to originate in the
      gastroduodenal region with no evidence of structural disease that is likely to explain the
      symptoms. The cause of this condition is unclear, not being a recognized treatment for it.
      The conventional treatments for those patients are symptom based. Unfortunately, these
      medications are not very effective. Patients with FD report poorer health status, mental
      health, and social functioning than patients with structural gastrointestinal pathology. Our
      aim is to compare a combined intervention (medical plus psychological intervention) versus
      conventional intervention (medical intervention)in regard to the health related quality of
      life, symptomatology, anxiety and depression of those patients. The investigators
      hypothesized that compared with conventional intervention a combined intervention would yield
      significantly better short (after treatment) and medium term (six months after treatment)
      improvement of health related quality of life and symptoms.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Patients were recruited from the digestive services of Galdakao-Usansolo and Basurto
      hospitals. They were randomly allocated to the control or experimental group. 82 patients
      were included in the control group and 76 in the experimental group.

      Regarding the intervention, the treatment of the control group was a conventional (medical)
      intervention. It was focused on the most bothersome symptom. Prokinetic (for example
      cinitapride) or antisecretory agent (for example omeprazole) was prescribed in standard dose.
      Experimental group received the combined intervention (medical plus psychological
      intervention). The psychological support consisted of ten weekly sessions, which the first 8
      were in group and the last 2 were individuals. In those sessions the patients received a) an
      information session to increase the patients' knowledge of functional dyspepsia; b) a Beck's
      cognitive-behavioural therapy focused on modifying the influence of some cognitive issues to
      gastrointestinal symptoms; c) and progressive-muscle relaxation according to Jacobson, with
      the aim to provide the ability to relax in certain stress situations. This technique was
      created for reducing anxiety by alternately tensing and relaxing the muscles.

      All the patients completed all the self questionnaires at baseline (t0), at the end of the
      treatment (T1) and at six months follow up (T2). The health related quality of life was
      assessed by the Dyspepsia Related Health Scale (DRHS), and anxiety and depression were
      assessed by the Hospital Anxiety and Depression Scale (HADS). Finally, the subjective
      clinical improvement was also considered and it was measured by a question about how they
      feel in regard to the functional dyspepsia, with five alternatively responses (a) Much
      better, b) quite a lot better, c) somewhat better, d) about the same, e) somewhat worse, f)
      quite a lot worse, g) much worse).
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>March 2009</start_date>
  <completion_date type="Actual">December 2012</completion_date>
  <primary_completion_date type="Actual">September 2012</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Supportive Care</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Change From Baseline in DYSPEPSIA RELATED HEALTH SCALE (DRHS)</measure>
    <time_frame>Participants will be followed at the recruit moment (t0) after treatment (t1) and six months after treatment (t2)</time_frame>
    <description>The Dyspepsia Related Health Scale (DRHS) is a self-reported dyspepsia-specific questionnaire that consists of four scales: severity of common symptoms, pain intensity, pain disability, and satisfaction with dyspepsia-related health. The score, for each scale, ranges between 0 and 100, with 0 representing the most severe situation and 100 the least severe. It also yields a global score that ranges from 0 to 100, with higher scores indicating less severe dyspepsia. The adapted and validated Spanish version of this questionnaire is known as QoL-PEI (Quality of Life in relation to Stomach and Intestinal Problems Questionnaire). Its reliability was found to be satisfactory (Cronbach's alpha 0.92). Its factorial analysis confirmed the four scales found by the DRHS but added a global score scale. The convergent validity was moderate (0.54).</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Subjective Clinical Improvement</measure>
    <time_frame>Subjective clinical improvement it is measured after treatment (t1) and six months after treatment (t2)</time_frame>
    <description>Subjective clinical improvement was measured by a question about how patients feel in regard to the functional dyspepsia (&quot;In relation to functional dyspepsia, how would you rate your health now? a)much better; b) quite a lot better; c) somewhat better; d) about the same; e) somewhat worse; f) quite a lot worse; g) much worse</description>
  </secondary_outcome>
  <other_outcome>
    <measure>Hospital Anxiety and Depression Scale</measure>
    <time_frame>Participants will be followed at the recruit moment (t0) after treatment (t1) and six months after treatment (t2)</time_frame>
    <description>It is a 14-item measure: 7 items evaluate depression (the HADS-D subscale) and 7 evaluate anxiety (the HADS-A subscale). For each subscale items range from 0 to 21. A subscale score of 0-7 indicates the absence of anxiety or depression; a score of 8-10 indicates a possible case of anxiety or depression; and a score of 11 or higher indicates the presence of anxiety or depression. It has been adapted and validated in a Spanish population</description>
  </other_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Actual">158</enrollment>
  <condition>Psychogenic Dyspepsia</condition>
  <arm_group>
    <arm_group_label>Psychological support</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Ten weekly sessions, which the first 8 were in group and the last 2 were individuals. It consists on a) an informational session; b) Beck's cognitive-behavioural therapy; and c) progressive-muscle relaxation according to Jacobson</description>
  </arm_group>
  <arm_group>
    <arm_group_label>No psychological support</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Patients of this group only received the conventional medical treatment, not receiving any psychological support</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Psychological support</intervention_name>
    <arm_group_label>Psychological support</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>No intervention</intervention_name>
    <arm_group_label>No psychological support</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  to have chronic upper abdominal symptoms consistent with ROME III criteria for
             functional dyspepsia

          -  to have an endoscopy to exclude structural organic causes at the time of the
             recruitment

        Exclusion Criteria:

          -  to have any organic pathology that could explain the dyspeptic symptoms

          -  to be using non-steroidal anti-inflammatory drugs (NSAIDs)

          -  to suffer physical or psychological impairments preventing them from properly
             completing the questionnaires
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>80 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Victor Manuel Orive, Doctor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Basurto University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jose Luis Cabriada, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Galdakao-Usansolo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Aitor Orive, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Galdakao-Usansolo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Bego√±a Matellanes, Psychology</last_name>
    <role>Study Chair</role>
    <affiliation>University of Deusto</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Maria Josefa Ulloa, Nurse</last_name>
    <role>Study Chair</role>
    <affiliation>Basurto University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jesus Angel Padierna, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Galdakao-Usansolo</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Escobar, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Basurto University Hospital</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Antonio Bernal, Doctor</last_name>
    <role>Study Chair</role>
    <affiliation>Hospital Galdakao-Usansolo</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Galdakao-Usansolo Hospital</name>
      <address>
        <city>Usansolo</city>
        <state>Bizkaia</state>
        <zip>48960</zip>
        <country>Spain</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <results_reference>
    <citation>Orive M, Barrio I, Orive VM, Matellanes B, Padierna JA, Cabriada J, Orive A, Escobar A, Quintana JM. A randomized controlled trial of a 10 week group psychotherapeutic treatment added to standard medical treatment in patients with functional dyspepsia. J Psychosom Res. 2015 Jun;78(6):563-8. doi: 10.1016/j.jpsychores.2015.03.003. Epub 2015 Mar 11.</citation>
    <PMID>25791668</PMID>
  </results_reference>
  <verification_date>March 2019</verification_date>
  <study_first_submitted>February 25, 2013</study_first_submitted>
  <study_first_submitted_qc>February 28, 2013</study_first_submitted_qc>
  <study_first_posted type="Estimate">March 1, 2013</study_first_posted>
  <results_first_submitted>August 22, 2016</results_first_submitted>
  <results_first_submitted_qc>March 25, 2019</results_first_submitted_qc>
  <results_first_posted type="Actual">June 21, 2019</results_first_posted>
  <last_update_submitted>March 25, 2019</last_update_submitted>
  <last_update_submitted_qc>March 25, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">June 21, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Hospital Galdakao-Usansolo</investigator_affiliation>
    <investigator_full_name>Miren Orive Calzada</investigator_full_name>
    <investigator_title>Msc</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Dyspepsia</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <group_list>
        <group group_id="P1">
          <title>Psychological Support</title>
          <description>Ten weekly sessions, which the first 8 were in group and the last 2 were individuals. It consists on a) an informational session; b) Beck's cognitive-behavioural therapy; and c) progressive-muscle relaxation according to Jacobson
Psychological support + conventional medical treatment</description>
        </group>
        <group group_id="P2">
          <title>No Psychological Support</title>
          <description>Patients of this group only received the conventional medical treatment, not receiving any psychological support
Only conventional medical treatment</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>From T0 to T1</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="76"/>
                <participants group_id="P2" count="82"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="72"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="16"/>
                <participants group_id="P2" count="10"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
        <period>
          <title>From T1 to T2</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="60"/>
                <participants group_id="P2" count="72"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="58"/>
                <participants group_id="P2" count="70"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="2"/>
                <participants group_id="P2" count="2"/>
              </participants_list>
            </milestone>
          </milestone_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <population>In certain analyzes we lose some subjects, for example when studying Subjective Clinical Improvement (here we have 60 patients in the experimental group and 69 in the control group)</population>
      <group_list>
        <group group_id="B1">
          <title>Psychological Support</title>
          <description>Ten weekly sessions, which the first 8 were in group and the last 2 were individuals. It consists on a) an informational session; b) Beck's cognitive-behavioural therapy; and c) progressive-muscle relaxation according to Jacobson
Psychological support + conventional medical treatment</description>
        </group>
        <group group_id="B2">
          <title>No Psychological Support</title>
          <description>Patients of this group only received the conventional medical treatment, not receiving any psychological support
No psychological intervention</description>
        </group>
        <group group_id="B3">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="76"/>
            <count group_id="B2" value="82"/>
            <count group_id="B3" value="158"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="44.28" spread="14.06"/>
                    <measurement group_id="B2" value="47.09" spread="15.19"/>
                    <measurement group_id="B3" value="45.73" spread="14.67"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Sex: Female, Male</title>
          <units>Participants</units>
          <param>Count of Participants</param>
          <class_list>
            <class>
              <category_list>
                <category>
                  <title>Female</title>
                  <measurement_list>
                    <measurement group_id="B1" value="64"/>
                    <measurement group_id="B2" value="66"/>
                    <measurement group_id="B3" value="130"/>
                  </measurement_list>
                </category>
                <category>
                  <title>Male</title>
                  <measurement_list>
                    <measurement group_id="B1" value="12"/>
                    <measurement group_id="B2" value="16"/>
                    <measurement group_id="B3" value="28"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Spain</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="76"/>
                    <measurement group_id="B2" value="82"/>
                    <measurement group_id="B3" value="158"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Change From Baseline in DYSPEPSIA RELATED HEALTH SCALE (DRHS)</title>
        <description>The Dyspepsia Related Health Scale (DRHS) is a self-reported dyspepsia-specific questionnaire that consists of four scales: severity of common symptoms, pain intensity, pain disability, and satisfaction with dyspepsia-related health. The score, for each scale, ranges between 0 and 100, with 0 representing the most severe situation and 100 the least severe. It also yields a global score that ranges from 0 to 100, with higher scores indicating less severe dyspepsia. The adapted and validated Spanish version of this questionnaire is known as QoL-PEI (Quality of Life in relation to Stomach and Intestinal Problems Questionnaire). Its reliability was found to be satisfactory (Cronbach's alpha 0.92). Its factorial analysis confirmed the four scales found by the DRHS but added a global score scale. The convergent validity was moderate (0.54).</description>
        <time_frame>Participants will be followed at the recruit moment (t0) after treatment (t1) and six months after treatment (t2)</time_frame>
        <population>the number analyzed in the rows differs from overall number analyzed because, as it is occur in follow-up studies, patients were lost from T0 to T1.</population>
        <group_list>
          <group group_id="O1">
            <title>Psychological Support</title>
            <description>Ten weekly sessions, which the first 8 were in group and the last 2 were individuals. It consists on a) an informational session; b) Beck's cognitive-behavioural therapy; and c) progressive-muscle relaxation according to Jacobson
Psychological support + conventional medical treatment</description>
          </group>
          <group group_id="O2">
            <title>No Psychological Support</title>
            <description>Patients of this group only received the conventional medical treatment, not receiving any psychological support
No psychological intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Change From Baseline in DYSPEPSIA RELATED HEALTH SCALE (DRHS)</title>
          <description>The Dyspepsia Related Health Scale (DRHS) is a self-reported dyspepsia-specific questionnaire that consists of four scales: severity of common symptoms, pain intensity, pain disability, and satisfaction with dyspepsia-related health. The score, for each scale, ranges between 0 and 100, with 0 representing the most severe situation and 100 the least severe. It also yields a global score that ranges from 0 to 100, with higher scores indicating less severe dyspepsia. The adapted and validated Spanish version of this questionnaire is known as QoL-PEI (Quality of Life in relation to Stomach and Intestinal Problems Questionnaire). Its reliability was found to be satisfactory (Cronbach's alpha 0.92). Its factorial analysis confirmed the four scales found by the DRHS but added a global score scale. The convergent validity was moderate (0.54).</description>
          <population>the number analyzed in the rows differs from overall number analyzed because, as it is occur in follow-up studies, patients were lost from T0 to T1.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change from t0 to t1 in DRHS-severity symptoms</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="60"/>
                    <count group_id="O2" value="72"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="73.72" spread="16.76"/>
                    <measurement group_id="O2" value="65.31" spread="17.60"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Change from t0 to t2 in DRHS-severity symptoms</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="71.85" spread="20.46"/>
                    <measurement group_id="O2" value="64.89" spread="19.22"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Subjective Clinical Improvement</title>
        <description>Subjective clinical improvement was measured by a question about how patients feel in regard to the functional dyspepsia (&quot;In relation to functional dyspepsia, how would you rate your health now? a)much better; b) quite a lot better; c) somewhat better; d) about the same; e) somewhat worse; f) quite a lot worse; g) much worse</description>
        <time_frame>Subjective clinical improvement it is measured after treatment (t1) and six months after treatment (t2)</time_frame>
        <group_list>
          <group group_id="O1">
            <title>Psychological Support</title>
            <description>Ten weekly sessions, which the first 8 were in group and the last 2 were individuals. It consists on a) an informational session; b) Beck's cognitive-behavioural therapy; and c) proressive-muscle relaxation according to Jacobson
Psychological support + conventional medical treatment</description>
          </group>
          <group group_id="O2">
            <title>No Psychological Support</title>
            <description>Patients of this group only received the conventional medical treatment, not receiving any psychological support
No psychological intervention</description>
          </group>
        </group_list>
        <measure>
          <title>Subjective Clinical Improvement</title>
          <description>Subjective clinical improvement was measured by a question about how patients feel in regard to the functional dyspepsia (&quot;In relation to functional dyspepsia, how would you rate your health now? a)much better; b) quite a lot better; c) somewhat better; d) about the same; e) somewhat worse; f) quite a lot worse; g) much worse</description>
          <units>Participants</units>
          <param>Count of Participants</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="60"/>
                <count group_id="O2" value="69"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Better in relation to functional dyspepsia at T1</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="37"/>
                    <measurement group_id="O2" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Better in relation to functional dyspepsia at T2</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="36"/>
                    <measurement group_id="O2" value="26"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
      <outcome>
        <type>Other Pre-specified</type>
        <title>Hospital Anxiety and Depression Scale</title>
        <description>It is a 14-item measure: 7 items evaluate depression (the HADS-D subscale) and 7 evaluate anxiety (the HADS-A subscale). For each subscale items range from 0 to 21. A subscale score of 0-7 indicates the absence of anxiety or depression; a score of 8-10 indicates a possible case of anxiety or depression; and a score of 11 or higher indicates the presence of anxiety or depression. It has been adapted and validated in a Spanish population</description>
        <time_frame>Participants will be followed at the recruit moment (t0) after treatment (t1) and six months after treatment (t2)</time_frame>
        <population>The number analyzed in the rows differs from overall number analyzed because, as it is occur in follow-up studies, patients were lost from T0 to T2.</population>
        <group_list>
          <group group_id="O1">
            <title>Psychological Support</title>
            <description>Ten weekly sessions, which the first 8 were in group and the last 2 were individuals. It consists on a) an informational session; b) Beck's cognitive-behavioural therapy; and c) progressive-muscle relaxation according to Jacobson
Psychological support + conventional medical treatment</description>
          </group>
          <group group_id="O2">
            <title>No Psychological Support</title>
            <description>Patients of this group only received the conventional medical treatment, not receiving any psychological support
Only conventional medical treatment</description>
          </group>
        </group_list>
        <measure>
          <title>Hospital Anxiety and Depression Scale</title>
          <description>It is a 14-item measure: 7 items evaluate depression (the HADS-D subscale) and 7 evaluate anxiety (the HADS-A subscale). For each subscale items range from 0 to 21. A subscale score of 0-7 indicates the absence of anxiety or depression; a score of 8-10 indicates a possible case of anxiety or depression; and a score of 11 or higher indicates the presence of anxiety or depression. It has been adapted and validated in a Spanish population</description>
          <population>The number analyzed in the rows differs from overall number analyzed because, as it is occur in follow-up studies, patients were lost from T0 to T2.</population>
          <units>units on a scale</units>
          <param>Mean</param>
          <dispersion>Standard Deviation</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="76"/>
                <count group_id="O2" value="82"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Change From t0 to t1 in HADS-D</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="72"/>
                    <count group_id="O2" value="60"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="8.95" spread="1.95"/>
                    <measurement group_id="O2" value="9.31" spread="2.00"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>From t0 to t2in HADS-D</title>
              <analyzed_list>
                <analyzed>
                  <units>Participants</units>
                  <scope>Class</scope>
                  <count_list>
                    <count group_id="O1" value="58"/>
                    <count group_id="O2" value="70"/>
                  </count_list>
                </analyzed>
              </analyzed_list>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9.09" spread="1.88"/>
                    <measurement group_id="O2" value="9.71" spread="2.01"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </outcome>
    </outcome_list>

    <reported_events>
      <desc>&quot;0&quot; Total Number of Participants at Risk: All-Cause Mortality, Serious and other adverse events were not monitored/assessed</desc>
      <group_list>
        <group group_id="E1">
          <title>Psychological Support</title>
          <description>Ten weekly sessions, which the first 8 were in group and the last 2 were individuals. It consists on a) an informational session; b) Beck's cognitive-behavioural therapy; and c) progressive-muscle relaxation according to Jacobson
Psychological support</description>
        </group>
        <group group_id="E2">
          <title>No Psychological Support</title>
          <description>Patients of this group only received the conventional medical treatment, not receiving any psychological support
No intervention</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="0"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="0"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <point_of_contact>
      <name_or_title>Dra Miren Orive</name_or_title>
      <organization>Hospital Galdakao-Usansolo</organization>
      <phone>0034 944007105</phone>
      <email>miren.orivecalzada@osakidetza.net</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

